Bifogade filer
PDF
Kurs & Likviditet
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Bioteknik |
Cline Scientific announces the appointment of Professor Emeritus and Orthopedic Surgeon Lars Peterson as a new advisor for StemCART, Cline's cell-based cartilage repair product.
Lars Peterson has been a hugely influential figure in Orthopedics and Sports Medicine in Sweden and worldwide. Peterson was a pioneer of the autologous chondrocyte transplantation procedure for the repair of articular cartilage. Throughout his long career, Peterson has been a world-renowned orthopedic surgeon, was appointed Professor of Orthopaedic Surgery at the University of Gothenburg, and served as head physician of the Swedish national team for both ice hockey and soccer. For 38 years, Lars Peterson has been a member of the Sports Medical Committee of FIFA and a founding member of F-MARC (FIFA Medical Assessment and Research Center). In addition, he was one of the founders of ICRS (International Cartilage Regeneration and Joint Repair Society). He served as president from 2001 to 2002.
Peterson has received many accolades throughout his long career, including being the elected member of The Hall of Fame of the American Orthopaedic Society of Sports Medicine in 2007. He received the Duke of Edinburgh Prize for Outstanding contribution to international education in Sports Medicine. In 2010, he was awarded Doctor Honoris Causa at the University of Helsinki, Finland, and in 2011 he was awarded Doctor Honoris Causa at Universidad Catolica San Antonio, Spain. He has published more than 200 articles, reviews, and book chapters.
Professor Emeritus Lars Peterson will add to Cline's growing clinical advisor team. He will provide important clinical insights and help Cline bring new pioneering cartilage repair strategies to the forefront of the field.
"The addition of Professor Peterson to the StemCART team is an achievement in itself. His extensive experience, both in the clinic and as one of the pioneers in the cell therapy area, will lend invaluable insights to our project. The enthusiasm and willingness to contribute he exhibits is an inspiration to the team to drive StemCART to a success! We welcome Professor Peterson and hope we can inspire him as much as he inspires us." - Patrik Sundh, CEO.
For more information, please contact:
Patrik Sundh, CEO
Email: patrik.sundh@clinescientific.com
Phone: +46 0703585088